• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Orchid Pharma Ltd.
    01 Jul 2024
    705.80
    -1.23%
    Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India
    Business Standard
    The rise came following Orchid Pharma's announcement of a collaboration with pharmaceutical giant Cipla to introduce the antibiotic Cefepime-Enmetazobactam in India
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd. is trading below all available SMAs
    P
    Panchsheel Organics Ltd.
    28 Jun 2024
    142.75
    -1.99%
    China's Xi Jinping lauds relevance of 'Panchsheel' to end world conflicts
    Business Standard
    "The Five Principles have set a historic benchmark for international relations and international rule of law," he said, highlighting their relevance to ending the present-day conflicts
    Copy LinkShare onShare on Share on Share on
    Panchsheel Organics Ltd. has lost -47.65% in the last 1 Year
    logo
    Orchid Pharma Ltd.
    28 Jun 2024
    705.80
    -1.23%
    Orchid Pharma ties up with Cipla for new UTI drug's distribution
    Business Line
    It is estimated that the drug sales could reach an annual value of about 100 crore, in about 2-3 years
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd. is trading below all available SMAs
    Orchid Pharma join hands with Cipla to launch new antibiotic in India
    Business Standard | 28 Jun 2024
    logo
    Aurobindo Pharma Ltd.
    28 Jun 2024
    US FDA Observation High Gain High Volume
    1109.20
    5.61%
    Aurobindo Pharma Unit Acquires Ace Laboratories For Rs 18 Crore
    Aurobindo Pharma Unit Acquires Ace Laboratories For Rs 18 Crore
    NDTV Profit
    The company was acquired for nearly Rs 18 crore on a debt-free basis.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. is trading at high volume of 5.9M with price gain of 5.61.
    logo
    Wockhardt Ltd.
    28 Jun 2024
    1527.30
    -2.09%
    Wockhardt's novel antibiotic Zaynich to be launched in India by end of FY25
    Business Standard
    Global launch in FY26 after multinational clinical trial ends
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. is trading below its 50 day SMA of 1595.2
    Wockhardt's investigational antibiotic shows significant effectiveness in global Phase 3 trials
    Business Today | 28 Jun 2024
    logo
    Wockhardt Ltd.
    28 Jun 2024
    1527.30
    -2.09%
    Wockhardt Launches New Antibiotic With $25-Billion Market Potential
    Wockhardt Launches New Antibiotic With $25-Billion Market Potential
    NDTV Profit
    The company has invested over $500 million on its research efforts till now.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.60% of shares in last quarter. Total pledge stands at 15.64% of promoter holdings
    logo
    Acutaas Chemicals Ltd.
    28 Jun 2024
    1472.80
    0.99%
    Broker's call: Ami Organics (Buy)
    Business Line
    Proceeds from this exercise will be allocated towards future capital expenditure initiatives including establishment of captive solar power projects and debt repayment
    Copy LinkShare onShare on Share on Share on
    Acutaas Chemicals Ltd. is trading above all available SMAs
    logo
    Natco Pharma Ltd.
    28 Jun 2024
    Insider Trades
    848.25
    0.47%
    Natco Pharma mulling acquisition in RoW market to strengthen base business
    Business Line
    Hyderabad-based Natco has been taking steps to expand its reach and recently invested approximately $2 million in Cellogen Therapeutics Private Ltd,a Delhi based biotech start-up
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. is trading below all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    28 Jun 2024
    US FDA Observation Acquisition
    1303.10
    -0.08%
    Dr. Reddy's - To Acquire Global OTC Portfolio For Ex-U.S. Market: HDFC Securities
    Dr. Reddy's - To Acquire Global OTC Portfolio For Ex-U.S. Market: HDFC Securities
    NDTV Profit
    The closing of the transaction is subject to satisfactory completion of customary conditions, including regulatory approvals, and it is expected to close in early Q4 CY24.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
    Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition
    Business Standard | 27 Jun 2024 5 more
    Dr Reddy's At One-Month High On Arm Buying British Nicotine Gum Brand
    NDTV Profit | 27 Jun 2024
    Dr Reddy's shares zoom post Nicotinell acquisition; brokerages unimpressed
    Business Standard | 27 Jun 2024
    Dr. Reddy's to acquire Nicotinell portfolio products for 500 m
    Business Line | 26 Jun 2024
    Dr. Reddy's to acquire Haleon's nicotine replacement biz for 500 mn pounds
    Business Standard | 26 Jun 2024
    Dr Reddy's To Acquire Haleon's Anti-Tobacco Therapy Portfolio
    NDTV Profit | 26 Jun 2024
    logo
    Neuland Laboratories Ltd.
    27 Jun 2024
    High Gain High Volume
    15554.00
    5.07%
    Neuland Laboratories - Improved Products Mix To Drive Growth: DRChoksey
    Neuland Laboratories - Improved Products Mix To Drive Growth: DRChoksey
    NDTV Profit
    The management also believes that improved business is likely over medium term with the ramp up in CMS and specialty.
    Copy LinkShare onShare on Share on Share on
    Neuland Laboratories Ltd. is trading at high volume of 173.9K with price gain of 5.07.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd